Life
Pharmacy Benefit Managers Challenge Trump's Drug Price Transparency Proposal
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
Editorial Staff
1 min read
Updated 1 day ago
Summary
Pharmacy benefit managers, key players in the pharmaceutical industry, are expressing concerns over a proposal put forth by former President Trump that seeks to mandate the disclosure of drug prices.
These industry middlemen argue that the proposal could be illegal, raising questions about its implementation and potential impact on the market.
As the debate over drug pricing continues, the push for transparency remains a contentious issue among stakeholders in the healthcare sector.
Key Facts
- Key facts pending editorial review.
Updates
- No subsequent updates recorded.